ARTG 470228Gastro-oesophageal antireflux barrier
ARTG ID: 470228 · ENT Technologies Pty Ltd · DMG Italia Srl · Class IIa · Started November 25, 2024
Good Name: ENT Technologies Pty Ltd - Gastro-oesophageal antireflux barrier
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 470228
- Start Date
- November 25, 2024
- Effective Date
- November 25, 2024
- Name
- DMG Italia Srl
- Country
- Italy
- Address
- Via Laurentina Km 26, Pomezia, Rome, 700-00071
Oral spray intended for the temporary relief of symptoms from gastric acid reflux by the use of a protective mucoadhesive lining on the tissues of the oropharynx. This device is available [non-prescription] over-the-counter (OTC) for home use and may be used to releive the symptoms of gastro-oesophageal reflux disease (GERD) of various causes which include pharyngeal dryness or irritation, constant throat clearing, lump in the throat sensation and dry cough.
Access comprehensive regulatory information for Gastro-oesophageal antireflux barrier in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 470228 and sponsored by ENT Technologies Pty Ltd, manufactured by DMG Italia Srl in Italy. The device registration started on November 25, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.